Refracture

再断裂
  • 文章类型: Journal Article
    已知患有髋部骨折的患者处于即将发生的再骨折风险。他们复杂的多学科康复需要包括预防跌倒和抗骨质疏松药物(AOM)以防止此类骨折。本研究旨在确定哪些医院级别的组织因素可以预测髋部骨折后AOM的处方。和再骨折的风险。在英格兰和威尔士(2016-19)接受了174757名年龄≥60岁的髋部骨折患者的队列检查并随访了1年。来自172家医院的患者级住院数据集,国家髋部骨折数据库,死亡率数据与从18份医院级组织报告中提取的71项指标相关联.多层次模型确定了组织因素,独立于患者病例组合,与(I)AOM处方相关,(ii)再断裂(通过ICD10编码)。患者平均(SD)82.7(8.6)岁,71%为女性,18%的人从养老院入院。总的来说,101735(57%)在入院期间规定了AOM;而50354(28%)在1年随访期间死亡,12240(7%)折射。12个组织因素与AOM处方相关,例如,与传统护理模式相比(OR4.65[95CI:2.25-9.59]);在向所有患者提供常规骨健康评估的医院中,使用AOM的可能性高出9%(95CI:6%-13%).再骨折发生在中位数126天(IQR59-234)。八个组织因素与再骨折风险相关;在入院72小时内向所有患者提供矫形儿科医生评估的医院再骨折风险降低了18%(95CI:2-31%)。周末物理治疗提供8%(95CI:3-14%)的风险降低,职业治疗师参加了临床治理会议,风险降低7%(95CI:2-12%)。延迟启动出院后社区康复与15%(95CI:3-29%)的再骨折风险相关。这些小说,国家研究结果强调了矫形儿科医生的重要性,物理治疗师和职业治疗师参与了髋部骨折后的二次骨折预防;值得注意的是,髋部骨折后12个月内骨折风险降低。
    髋部骨折(骨折)的患者在不久后有再次骨折的风险。他们有复杂的需求来避免更多的骨折,其中包括开强骨药物和采取措施防止跌倒。这项研究着眼于哪种测量,描述医院组织得有多好,与是否开了强骨药以及再次骨折的机会有关。我们使用了来自172个英国和威尔士医院的178,757名年龄超过60岁的髋部骨折患者的数据,和他们的医院记录有关,和其他描述医院服务的数据集。总的来说,57%的患者服用了强骨药物,7%的人再次骨折。骨强化药物更有可能在由专门为骨折老年人提供护理的顾问领导的医院和定期检查患者骨骼健康的医院中开药。在入院后72小时内向所有患者提供骨科医师评估的医院就诊的患者,周末的理疗服务,或者职业治疗师参加旨在改善医院服务的会议的地方发生另一次骨折的可能性较低。
    Patients who sustain a hip fracture are known to be at imminent refracture risk. Their complex multidisciplinary rehabilitation needs to include falls prevention and anti-osteoporosis medication (AOM) to prevent such fractures. This study aimed to determine which hospital-level organisational factors predict prescription of post-hip fracture AOM, and refracture risk. A cohort of 178 757 patients aged ≥60 years who sustained a hip fracture in England and Wales (2016-19) was examined and followed for 1 year. Patient-level hospital admission datasets from 172 hospitals, the National Hip Fracture Database, and mortality data were linked to 71 metrics extracted from 18 hospital-level organisational reports. Multilevel models determined organisational factors, independent of patient case-mix, associated with (i) AOM prescription, (ii) refracture (by ICD10 coding). Patients were mean (SD) 82.7 (8.6) years old, 71% female, with 18% admitted from care homes. Overall, 101 735 (57%) were prescribed AOM during admission; while 50 354 (28%) died during 1-year follow-up, 12 240 (7%) refractured. Twelve organisational factors were associated with AOM prescription, e.g., orthogeriatrician-led care compared to traditional care models (OR 4.65 [95%CI: 2.25-9.59]); AOM was 9% (95%CI: 6%-13%) more likely to be prescribed in hospitals providing routine bone health assessment to all patients. Refracture occurred at median 126 days (IQR 59-234). Eight organisational factors were associated with refracture risk; hospitals providing orthogeriatrician assessment to all patients within 72-hours of admission had an 18% (95%CI: 2-31%) lower refracture risk, weekend physiotherapy provision an 8% (95%CI: 3-14%) lower risk, and where occupational therapists attended clinical governance meetings, a 7% (95%CI: 2-12%) lower risk. Delays initiating post-discharge community rehabilitation were associated with a 15% (95%CI: 3-29%) greater refracture risk. These novel, national findings highlight the importance of orthogeriatrician, physiotherapist and occupational therapist involvement in secondary fracture prevention post hip fracture; notably fracture risk reductions were seen within 12 months of hip fracture.
    Patients who have broken (fractured) a hip are at risk of having another fracture soon after. They have complex needs to avoid more fractures, which include being prescribed bone-strengthening medicines and taking measures to prevent falls. This study looked at which of the measurements, that describe how well a hospital is organised, are associated with whether bone-strengthening medicine is prescribed and the chance of having another fracture. We used data from 178 757 patients aged over 60 years who had a hip fracture at 172 English and Welsh hospitals, linked to their hospital records, and other datasets that describe hospital services. Overall, 57% of patients were prescribed bone-strengthening medicines, and 7% went on to have another fracture. Bone-strengthening medicines were more likely to be prescribed in hospitals where patient care was led by a consultant specialising in the care of older people with fractures (called orthogeriatricians) and in hospitals which routinely checked patients’ bone health. Patients attending hospitals that provided orthogeriatrician assessment to all patients within 72 hours of being admitted, physiotherapy services at the weekend, or where occupational therapists attended meetings aimed at improving hospital services had a lower chance of having another fracture.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:预测脊柱再骨折的人工智能(AI)模型的研究仅限于骨密度,X射线和一些常规的实验室指标,这有其自身的局限性。此外,缺乏与骨质疏松相关的特异性指标和能较好反映骨质量的影像学因素,如计算机断层扫描(CT)。
    目的:构建一种基于骨翻转标记和CT的新型预测模型,以识别更倾向于脊柱再骨折的患者。
    方法:383例患者的CT图像和临床信息(训练集=240例骨质疏松性椎体压缩性骨折(OVCF),从2015年1月至2022年10月,在三个医疗中心回顾性收集了验证集=63,测试集=80)。采用U-net模型自动分割ROI。所有脊柱区域的三维(3D)裁剪用于实现包括3D_Full和3D_RoiOnly的最终ROI区域。我们使用Densenet121-3D模型对裁剪区域进行建模,同时建立T-NIPT预测模型。通过构建ROC曲线评估深度学习模型的诊断。我们生成校准曲线以评估校准性能。此外,决策曲线分析(DCA)用于评估预测模型的临床应用.
    结果:测试模型的性能与其在训练集上的性能相当(骰子系数为0.798,mIOU为0.755,SA为0.767,OS为0.017)。单变量和多变量分析表明T_P1NT是再骨折的独立危险因素。预测不同ROI区域折射的性能表明,3D_Full模型具有最高的校准性能,Hosmer-Lemeshow拟合优度(HL)检验统计值超过0.05。对训练集和测试集的分析表明,3D_Full模型,整合了临床和深度学习结果,与独立使用临床特征或仅使用3D_RoiOnly相比,显示出具有显著改善的优异性能(p值<0.05)。
    结论:T_P1NT是再骨折的独立危险因素。我们的3D-FULL模型在预测脊柱再骨折高危人群方面比其他模型和初级医生表现更好。该模型由于其自动分割和检测而适用于现实世界的翻译。
    BACKGROUND: The reaserch of artificial intelligence (AI) model for predicting spinal refracture is limited to bone mineral density, X-ray and some conventional laboratory indicators, which has its own limitations. Besides, it lacks specific indicators related to osteoporosis and imaging factors that can better reflect bone quality, such as computed tomography (CT).
    OBJECTIVE: To construct a novel predicting model based on bone turn-over markers and CT to identify patients who were more inclined to suffer spine refracture.
    METHODS: CT images and clinical information of 383 patients (training set = 240 cases of osteoporotic vertebral compression fractures (OVCF), validation set = 63, test set = 80) were retrospectively collected from January 2015 to October 2022 at three medical centers. The U-net model was adopted to automatically segment ROI. Three-dimensional (3D) cropping of all spine regions was used to achieve the final ROI regions including 3D_Full and 3D_RoiOnly. We used the Densenet 121-3D model to model the cropped region and simultaneously build a T-NIPT prediction model. Diagnostics of deep learning models were assessed by constructing ROC curves. We generated calibration curves to assess the calibration performance. Additionally, decision curve analysis (DCA) was used to assess the clinical utility of the predictive models.
    RESULTS: The performance of the test model is comparable to its performance on the training set (dice coefficients of 0.798, an mIOU of 0.755, an SA of 0.767, and an OS of 0.017). Univariable and multivariable analysis indicate that T_P1NT was an independent risk factor for refracture. The performance of predicting refractures in different ROI regions showed that 3D_Full model exhibits the highest calibration performance, with a Hosmer-Lemeshow goodness-of-fit (HL) test statistic exceeding 0.05. The analysis of the training and test sets showed that the 3D_Full model, which integrates clinical and deep learning results, demonstrated superior performance with significant improvement (p-value < 0.05) compared to using clinical features independently or using only 3D_RoiOnly.
    CONCLUSIONS: T_P1NT was an independent risk factor of refracture. Our 3D-FULL model showed better performance in predicting high-risk population of spine refracture than other models and junior doctors do. This model can be applicable to real-world translation due to its automatic segmentation and detection.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:探讨肌少症对经皮椎体后凸成形术(PKP)治疗骨质疏松性椎体压缩骨折(OVCF)临床疗效的影响。方法:我们回顾性分析2021年9月至2022年8月接受经皮椎体后凸成形术(PKP)的单节段OVCF患者的病历。根据晚期骨骼肌指数(ASMI)将患者分为肌肉减少症组(43例)和非肌肉减少症组(125例)。收集和分析临床和放射学数据。结果:少肌症组和非少肌症组年龄差异无统计学意义,性别,骨矿物质密度(BMD),体重指数(BMI),断裂段,骨折类型,手术方法,骨水泥体积,骨水泥分布,合并症,术前和术后即刻VAS和ODI评分(P>0.05)。然而,步行的时间,住院,随访时的VAS和ODI得分,优秀/好率,非肌肉减少组的残余疼痛和再骨折发生率明显优于肌肉减少组(P<0.05)。同时,放射学结果,包括局部后凸和椎体高度损失率,在6个月和12个月的随访中,非肌肉减少组明显优于肌肉减少组(P<0.05)。结论:OVCF患者PKP术后的临床结局可能受到肌少症的负面影响。因此,在OVCF患者的治疗中应积极考虑肌少症的预防和治疗.
    Objective: This study aimed to explore the impact of sarcopenia on clinical outcomes after percutaneous kyphoplasty (PKP) for osteoporotic vertebral compression fracture (OVCF). Methods: We retrospectively analyzed the medical records of patients with single-segment OVCF who underwent percutaneous kyphoplasty (PKP) between September 2021 and August 2022. Patients were categorized into a sarcopenia group (43 patients) and a non-sarcopenia group (125 patients) based on their Advanced Skeletal Muscle Index (ASMI). Clinical and radiological data were collected and analyzed. Results: There were no significant differences between the sarcopenia and non-sarcopenia groups in age, sex, bone mineral density (BMD), body mass index (BMI), fractured segment, fracture type, surgical approach, bone cement volume, bone cement distribution, comorbidities, preoperative and immediate postoperative VAS and ODI scores (P > .05). However, the time to ambulation, hospital stays, VAS and ODI scores at follow-up, excellent/good rate, and the incidence of residual pain and re-fractures in the non-sarcopenia group were significantly better than those in the sarcopenia group (P < .05). Meanwhile, radiological outcomes, including regional kyphosis and vertebral height loss rate, were significantly better in the non-sarcopenia group than in the sarcopenia group at 6 and 12 month follow-ups (P < .05). Conclusion: Clinical outcomes after PKP in patients with OVCF could be negatively affected by sarcopenia. Therefore, prevention and treatment of sarcopenia should be actively considered in the management of patients with OVCF.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:老年人骨质疏松性椎体压缩性骨折(OVCF)增加术后再骨折风险,导致更高的死亡率。全基因组关联研究(GWAS)已经确定了骨质疏松症的易感基因,但是这些基因解释的表型变异是有限的,这表明需要探索其他因果因素。表观遗传修饰,比如DNA甲基化,可能影响骨质疏松症和再骨折的风险。然而,缺乏评估中国老年患者表观遗传改变的前瞻性队列。这里,我们建议进行前瞻性队列研究来调查DNA多态性的因果网络,DNA甲基化,和环境因素对骨质疏松症的发展和再骨折的风险。
    方法:我们将收集500名接受手术的老年OVCF患者的椎体和外周血,提取DNA,并生成全基因组基因型数据和DNA甲基化数据。将收集观察指标并与一年的随访数据相结合。健康对照组将从自然群体队列中选择。将进行骨质疏松症和骨矿物质密度的全基因组关联研究(EWAS)。差异甲基化分析将比较有和没有骨折的患者的候选基因甲基化模式。将建立使用遗传变异和DNA甲基化位点的多组学预测模型来预测OVCF风险。
    结论:这项研究将是第一个基于全基因组数据的骨质疏松症和骨密度表型的大规模人群研究,多时间点甲基化数据,和表型数据。通过分析OVCF患者骨质疏松和骨密度相关的甲基化变化,本研究将探讨DNA甲基化评估术后骨质疏松干预效果的可行性。这些发现可能为有效的抗骨质疏松治疗确定新的分子标志物,并为个体化的预防和治疗策略提供信息。
    背景:chictr.org.cnChiCTR2200065316,02/11/2022。
    BACKGROUND: Osteoporotic vertebral compression fractures (OVCF) in the elderly increase refracture risk post-surgery, leading to higher mortality rates. Genome-wide association studies (GWAS) have identified susceptibility genes for osteoporosis, but the phenotypic variance explained by these genes has been limited, indicating the need to explore additional causal factors. Epigenetic modifications, such as DNA methylation, may influence osteoporosis and refracture risk. However, prospective cohorts for assessing epigenetic alterations in Chinese elderly patients are lacking. Here, we propose to conduct a prospective cohort study to investigate the causal network of DNA polymorphisms, DNA methylation, and environmental factors on the development of osteoporosis and the risk of refracture.
    METHODS: We will collect vertebral and peripheral blood from 500 elderly OVCF patients undergoing surgery, extract DNA, and generate whole genome genotype data and DNA methylation data. Observation indicators will be collected and combined with one-year follow-up data. A healthy control group will be selected from a natural population cohort. Epigenome-wide association studies (EWAS) of osteoporosis and bone mineral density will be conducted. Differential methylation analysis will compare candidate gene methylation patterns in patients with and without refracture. Multi-omics prediction models using genetic variants and DNA methylation sites will be built to predict OVCF risk.
    CONCLUSIONS: This study will be the first large-scale population-based study of osteoporosis and bone mineral density phenotypes based on genome-wide data, multi-time point methylation data, and phenotype data. By analyzing methylation changes related to osteoporosis and bone mineral density in OVCF patients, the study will explore the feasibility of DNA methylation in evaluating postoperative osteoporosis intervention effects. The findings may identify new molecular markers for effective anti-osteoporosis treatment and inform individualized prevention and treatment strategies.
    BACKGROUND: chictr.org.cn ChiCTR2200065316, 02/11/2022.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    大创伤后的再骨折率大约是最小创伤后的再骨折率的一半(57%)。将骨折联络处的活动扩大到包括主要创伤患者,会产生大量额外的直接成本,但如果考虑到通过降低再骨折风险的名义节省,则基本上保持成本中立。
    目的:比较小创伤(MT)和非小创伤(非MT)损伤后3年的再骨折率,并评估将骨折联络服务(FLS)手术扩展到非MT表现的费用。
    方法:通过亨特新英格兰卫生服务(HNEHS)的综合患者管理系统(IPMS),确定了2018日历年到约翰·亨特医院就诊的50岁或以上骨折患者。并在接下来的3年内重新展示给任何HNEHS设施。使用Cox比例风险回归模型比较和分析了MT和非MT表现的再骨折率。通过使用先前进行的微观成本分析来估计包括非MT患者的成本。通过比较两项研究中MT表现的3年再骨折率,证实了FLS与先前估计的操作保真度。
    结果:MT损伤后3年再骨折率为8%,非MT损伤后3年再骨折率为4.5%。2022年将FLS活动扩展到包括非MT患者将额外花费$198,326AUD,通过减少再骨折风险,名义损失/节省$-26,625/+26,913AUD。没有发现临床上可预测再骨折风险增加的特征。
    结论:非MT损伤后3年再骨折约为MT损伤后再骨折率的一半(57%)。将FLS活动扩展到非MT患者会产生大量额外的直接成本,但如果考虑到通过降低再骨折风险而获得的名义节省,则保持成本中立。
    The refracture rate after major trauma is approximately half (57%) the refracture rate after a minimal trauma injury. Extending Fracture Liaison Service activity to include major trauma patients creates significant additional direct cost, but remains essentially cost neutral if notional savings through refracture risk reduction are taken into account.
    OBJECTIVE: To compare the 3-year refracture rate following minimal trauma (MT) and non-minimal trauma (non-MT) injuries and evaluate the cost of extending fracture liaison service (FLS) operations to non-MT presentations.
    METHODS: Patients aged 50, or above presenting to the John Hunter Hospital with a fracture in calendar year 2018 were identified through the Integrated Patient Management System (IPMS) of the Hunter New England Health Service\'s (HNEHS), and re-presentation to any HNEHS facility over the following 3 years monitored. The refracture rate of MT and non-MT presentations was compared and analysed using Cox proportional hazards regression models. The cost of including non-MT patients was estimated through the use of a previously conducted micro-costing analysis. The operational fidelity of the FLS to the previous estimate was confirmed by comparing the 3-year refracture rate of MT presentations in the two studies.
    RESULTS: The 3-year refracture rate following a MT injury was 8% and after non-MT injury 4.5%. Extension of FLS activities to include non-MT patients in 2022 would have cost an additional $198,326 AUD with a notional loss/saving of $ - 26,625/ + 26,913 AUD through refracture risk reduction. No clinically available characteristic at presentation predictive of increased refracture risk was identified.
    CONCLUSIONS: The 3-year refracture after a non-MT injury is about half (57%) that of the refracture rate after a MT injury. Extending FLS activity to non-MT patients incurs a significant additional direct cost but remains cost neutral if notional savings gained through reduction in refracture risk are taken into account.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:了解成人精神分裂症患者髋部骨折手术后的近期和长期结局。
    方法:利用安大略省卫生管理数据库的基于人群的回顾性队列研究,加拿大。纳入2009年4月1日至2019年3月31日期间进行髋部骨折手术的40-105岁个体。使用经过验证的算法确定精神分裂症。结果为:30天死亡率;30天再入院;1年生存率;以及2年内的髋部骨折。结合广义估计方程模型进行分析,卡普兰-迈耶曲线,和精细灰色竞争风险模型。
    结果:在这项98,126例手术治疗髋部骨折患者的队列研究中,[IQR]年龄中位数为83[75-89]岁,69.2%是女性,3700人(3.8%)患有精神分裂症。在Fine-Gray模型中,精神分裂症与随后的髋部骨折(sdRH,1.29;95%CI,1.09-1.53),男性精神分裂症患者在50天前再次骨折。在年龄和性别调整的GEE模型中,精神分裂症与30天死亡率相关(OR,1.31;95%CI,1.12-1.54)和再入院(OR,1.40;95%CI,1.25-1.56)。Kaplan-Meier生存曲线表明精神分裂症患者在1年时存活的可能性较小。
    结论:研究强调了髋部骨折合并精神分裂症患者对不良预后的易感性,包括再骨折,对理解可修改的护理过程以优化其恢复具有重要意义。
    OBJECTIVE: To understand immediate and long-term outcomes following hip fracture surgery in adults with schizophrenia.
    METHODS: Retrospective population-based cohort study leveraging health administrative databases from Ontario, Canada. Individuals aged 40-105 years with hip fracture surgery between April 1, 2009 and March 31, 2019 were included. Schizophrenia was ascertained using a validated algorithm. Outcomes were: 30-day mortality; 30-day readmission; 1-year survival; and subsequent hip fracture within 2 years. Analyses incorporated Generalized Estimating Equation models, Kaplan-Meier curves, and Fine-Gray competing risk models.
    RESULTS: In this cohort study of 98,126 surgically managed hip fracture patients, the median [IQR] age was 83[75-89] years, 69.2% were women, and 3700(3.8%) had schizophrenia. In Fine-Gray models, schizophrenia was associated with subsequent hip fracture (sdRH, 1.29; 95% CI, 1.09-1.53), with male patients with schizophrenia sustaining a refracture 50 days earlier. In age- and sex-adjusted GEE models, schizophrenia was associated with 30-day mortality (OR, 1.31; 95% CI, 1.12-1.54) and readmissions (OR, 1.40; 95% CI, 1.25-1.56). Kaplan-Meier survival curves suggested that patients with schizophrenia were less likely to be alive at 1-year.
    CONCLUSIONS: Study highlights the susceptibility of hip fracture patients with schizophrenia to worse outcomes, including refracture, with implications for understanding modifiable processes of care to optimize their recovery.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    目的:分析脊柱侧凸与骨质疏松性椎体压缩骨折(OVCFs)患者经皮椎体后凸成形术(PKP)后椎体再骨折的关系。
    方法:对2014年1月至2022年10月符合该标准的269例患者进行了回顾性研究。所有患者均行PKP,资料完整,随访时间>12个月。首先,在269例患者中证实脊柱侧弯是一个危险因素.第二,根据Cobb角对脊柱侧凸患者进行分组,以评估术后角度的影响.采用Cox比例风险回归分析和生存分析计算风险比和复发时间。
    结果:共有56例脊柱侧凸,其中18人在PKP后经历了折射。椎体折返的危险因素包括T评分<-3.0和脊柱侧凸的存在(均p<0.001)。结果表明,椎体骨折弧(T10-L4)在脊柱侧凸和椎体骨折中有很高的影响。当脊柱侧凸和最初骨折的椎骨位于T10-L4内时,椎骨再骨折的危险因素包括术后Cobb角≥20°(p=0.002)和角度增加(p=0.001)。平均复发时间为17.2(10.7-23.7)个月和17.6(7.9-27.3)个月,分别。
    结论:骨质疏松合并脊柱侧凸可显著增加OVCFs患者PKP术后椎体折返的风险。当脊柱侧凸和最初骨折的椎骨位于T10-L4内时,术后Cobb角≥20°和角度增加是椎骨折返的重要危险因素。
    OBJECTIVE: To analyze the association between scoliosis and vertebral refracture after percutaneous kyphoplasty (PKP) in patients with osteoporotic vertebral compression fractures (OVCFs).
    METHODS: A retrospective study was conducted on 269 patients meeting the criteria from January 2014 to October 2022. All patients underwent PKP with complete data and were followed-up for > 12 months. First, it was verified that scoliosis was a risk factor in 269 patients. Second, patients with scoliosis were grouped based on the Cobb angle to evaluate the impact of the post-operative angle. The cox proportional hazards regression analysis and survival analysis were used to calculate the hazard ratio and recurrence time.
    RESULTS: A total of 56 patients had scoliosis, 18 of whom experienced refractures after PKP. The risk factors for vertebral refractures included a T-score < - 3.0 and presence of scoliosis (both p < 0.001). The results indicated that the vertebral fractured arc (T10 - L4) was highly influential in scoliosis and vertebral fractures. When scoliotic and initially fractured vertebrae were situated within T10 - L4, the risk factors for vertebral refracture included a postoperative Cobb angle of ≥ 20° (p = 0.002) and an increased angle (p = 0.001). The mean recurrence times were 17.2 (10.7 - 23.7) months and 17.6 (7.9 - 27.3) months, respectively.
    CONCLUSIONS: Osteoporosis combined with scoliosis significantly increases the risk of vertebral refractures after PKP in patients with OVCFs. A postoperative Cobb angle of ≥ 20° and an increased angle are significant risk factors for vertebral refractures when scoliotic and initially fractured vertebrae are situated within T10 - L4.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    前言:背景/目的:胆碱酯酶是一种罕见的导致骨骼发育不良的遗传性疾病。它是由导致组织蛋白酶K缺乏的基因突变决定的,并使患者易患骨硬化,导致骨骼脆性增加。这种疾病典型的骨质量改变是骨折风险增加的原因。我们研究的目的是评估在我们机构接受治疗的一系列患者中,受肾盂畸形影响,在病理性骨折的手术治疗中,骨科表现和潜在的陷阱。方法:我们回顾性评估了过去5年来在我院接受病理性骨折治疗的5例骨盆骨折患者的临床和影像学特征。结果:2名男性和3名女性患者被纳入本研究。4例患者有肾结石症家族史。所有的病人都是身材矮小的,但只有两个人接受了生长激素治疗。所有的病人都有骨折,主要发生在他们的下肢,是低能量创伤的结果。大多数患者经历了巩固延迟或骨不连。结论:对于骨性骨痛患者的骨折的骨科处理对骨科医生构成了持续的挑战。骨骼同时硬化和脆性的事实使得任何整形外科治疗都具有挑战性,并且在任何情况下都有不愈合的高风险。
    Background/Objectives: Pycnodysostosis is a rare genetic disorder causing skeletal dysplasia. It is determined by a gene mutation leading to cathepsin K deficiency and predisposes a patient to osteosclerosis, resulting in increased bone fragility. The altered bone quality typical of this disease is responsible for an increased risk of fractures. The purpose of our study was to evaluate the orthopedic manifestations and potential pitfalls in the surgical treatments of pathological fractures in a series of patients treated in our institution who were affected by pycnodysostosis. Methods: We retrospectively evaluated clinical and radiographic characteristics of five patients with pycnodysostosis treated for pathological fractures at our hospital in the past 5 years. Results: Two male and three female patients were included in this study. Four patients had a family history of pycnodysostosis. All the patients were of short stature, but only two underwent growth hormone treatment. All the patients experienced fractures, mostly in their lower limbs and occurring as a result of low-energy trauma. Most of the patients experienced either consolidation delay or nonunion. Conclusions: The orthopedic management of fractures in patients with pycnodysostosis poses an ongoing challenge for orthopedic surgeons. The fact that the bone is simultaneously sclerotic and brittle makes any orthopedic surgical treatment challenging and at a high risk of nonunion in any case.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: English Abstract
    UNASSIGNED: To analyze the causes and treatment of off target of the distal interlocking screws when short cephalomeduallry nails were installed through jig-guided targeting device, and to put forward the technical points to prevent off target.
    UNASSIGNED: Retrospective analysis of 9 patients with intertrochanteric fractures treated between July 2014 and June 2023 was conducted, in which off target occurred during the insertion of the distal interlocking screw by jig-guided targeting device in short cephalomedullary nailling (<24 cm). There were 1 male and 8 females, with an average age of 82.7 years (range, 73-94 years). There were 3 cases of type A1, 5 cases of type A2, and 1 case of type A3 according to 2018-AO/Orthopaedic Trauma Association (AO/OTA) fracture classification. As for the misaligned distal interlocking screw, six parameters were collected and analyzed, including the time of finding, the position, the type of passing through the cortical bone, the special circumstances during operation (such as the need to remove the intramedullary nail for reaming the diaphysis, hammering, etc.), the treatment, and the patient follow-up results.
    UNASSIGNED: In the 9 patients, the off target of the distal interlocking screw was found in 7 cases during operation and in 2 cases after operation; the locking screw was located behind the nail in 7 cases and in front of the nail in 2 cases; the off target locking screw was passing tangentially in transcortical patern in 6 cases and in bicortical pattern through the medullary cavity in 3 cases. Three cases were attributed to the mismatch between the nail and the femur, two of which were attributed to the narrow femoral medullary cavity, one of which was attributed to the large anterolateral femoral bowing, and the other 6 cases were attributed to technical errors such as the loosening of the jig-guided targeting device, the tension of the fascia lata, and the blunt of the drill. In the 7 cases found during operation, the misaligned interlocking screw was removed first and the screw hole was left vacant, then in 2 cases, the interlocking screw was not used further; in 1 case, the distal dynamic hole was successfully inserted with a dynamic guide frame, and in 4 cases, the interlocking screw was successfully put after 2-3 attempts, leaving a large hole in the lateral cortex. No special treatment was performed in 2 cases found after operation. One patient was out of bed early after operation, 7 patients were in bed for 1 month, and 1 patient deteriorated to A3 type after operation and was in bed for 3 months. All the 9 patients were followed up 6-12 months, with an average of 8 months. Fracture healing was achieved in 8 patients. One patient with vacant interlocking screw had a secondary spiral fracture of the femoral shaft 3 months later, and was refixed with a long cephalomedullary nail and circlage wiring.
    UNASSIGNED: Distal interlocking screw off target is rare, but when it occurs, it leaves a large cortical hole in the osteoporotic femoral shaft, reducing bone strength; the use of precision instruments and attention to technical details can reduce this adverse phenomenon.
    UNASSIGNED: 分析短型头髓钉经体外框架导向器安装远侧交锁螺钉失准的原因、处理方法,并提出预防失准的技术要点。.
    UNASSIGNED: 2014年7月—2023年6月,9例股骨转子间骨折患者术中采用短型头髓钉(<24 cm)经体外框架导向器安装远侧交锁螺钉时发生螺钉失准。其中男1例,女8例;年龄73~94岁,平均82.7岁。2018-国际内固定研究协会/美国骨创伤协会(AO/OTA)骨折分型:A1型3例,A2型5例,A3型1例。分析失准发现时间、失准方位、失准螺钉穿过皮质骨的类型、术中特别情况(如需拔除髓内钉重新进行骨干扩髓、榔头敲击等)以及对失准情况的处理及随访结果。.
    UNASSIGNED: 9例患者中,远侧交锁螺钉失准为术中发现7例,术后发现2例;失准的远侧交锁螺钉位于髓内钉后方7例,前方2例;6例为不经过髓腔的皮质切线位贯穿,3例为经过髓腔的双皮质穿透。失准原因:3例归因于髓内钉与股骨不匹配,其中2例属于股骨髓腔过于狭小,1例股骨前外侧弓太大;另6例归因于操作失误,如导向架松动、阔筋膜张力、钻头迟钝等。术中发现的7例均先取出失准的交锁螺钉并空置该螺钉孔,其中2例不再打入交锁螺钉;1例换用动态导向架成功打入远侧的动态孔,4例在尝试2~3次后交锁成功,在外侧皮质遗留较大孔洞。术后发现的2例未做特殊处理。术后1例患者早期下床活动,7例卧床1个月,1例术后恶化为A3型,卧床3个月。9例患者均获随访,随访时间6~12个月,平均8个月。8例患者骨折愈合;1例交锁螺钉空置者术后3个月站立时发生经皮质孔洞的股骨干螺旋形骨折,再次手术换用长型头髓钉并捆扎固定。.
    UNASSIGNED: 远侧交锁螺钉失准情况比较少见,一旦发生将在骨质疏松的股骨干上遗留一较大皮质孔洞,降低骨强度;使用精密器械并注意操作细节可以减少此现象的发生。.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:再骨折是骨运输的主要并发症之一,这给手术和患者带来了额外的身心负担。我们旨在基于Simpson分类提出一种新的与再骨折相关的骨运输分类系统,并介绍我们的治疗经验。
    方法:该回顾性分析包括19例与再骨折相关的骨转运患者(平均年龄37.7岁;18例男性)。我们开发了一种改进的Simpson分类系统来辅助决策(保守与手术)。最后随访时使用ASAMI标准评估结果。
    结果:平均随访12.3±3.2个月。所有患者都实现了完全的结合,没有再感染。基于改进的辛普森分类,三种情况下的再骨折为Ia型(在再生区域内),Ib(再生区域的塌陷裂缝)在一种情况下,Ic(应力性骨折)三例,II(在再生骨和原始骨之间的交界处)在一种情况下,III(在对接地点)在9个案例中,和V(在远处)在两种情况下。保守治疗6例,手术治疗13例。保守组平均骨愈合时间为2.8±1.2个月,手术组为4.4±1.4个月。使用ASAMI标准进行的最终随访评估显示,所有患者的骨效果都很好。6名患者(31.6%)的功能表现优异,13例患者的功能良好。
    结论:改良的Simpson分类可以包括对接部位的再骨折和再生区的应力性骨折,并为确定适当的治疗策略提供一些指导。
    OBJECTIVE: Refracture is one of the main complications of bone transport, which brings additional physical and mental burden to surgeries and patients. We aimed to raise a new classification system of refracture-related bone transport based on the Simpson classification and to present our experience on treatment.
    METHODS: This retrospective analysis included 19 patients with refracture-related bone transport (average age of 37.7 years; 18 men). We developed a modified Simpson classification system to assist decision-making (conservative versus surgical). The ASAMI criteria were used to assess the outcomes at last follow-up.
    RESULTS: The mean follow-up was 12.3 ± 3.2 months. Complete union was achieved in all patients, with no reinfection. Based on the modified Simpson classification, refracture was Ia type (within regeneration area) in three cases, Ib (collapsed fracture at the regeneration area) in one case, Ic (stress fracture) in three cases, II (at the junction between the regenerate and original bone) in one case, III (at the docking site) in nine cases, and V (at distant site) in two cases. Refracture was managed conservatively in six cases and surgically in 13 cases. Average time to bone union was 2.8 ± 1.2 months in the conservative group versus 4.4 ± 1.4 months in the surgery group. Assessment at the final follow-up using the ASAMI criteria revealed excellent bone result in all patients, excellent functional results in six patients (31.6%), and good functional results in 13 patients.
    CONCLUSIONS: The modified Simpson classification could include refracture at the docking site and stress fracture in the regeneration zone and provide some guidance in determining the appropriate treatment strategy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号